GADD45B and hepatocellular carcinoma: Our investigation confirmed that low GADD45B levels in human HCC tissues were associated with advanced stage and poor patient survival rates, and ZY0511 inhibited HCC cell growth by restoring GADD45B expression in HCC cells.